6 Results for "

small cell lung carcinoma cell lines

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "small cell lung carcinoma cell lines" in MCE Product Catalog:

Art. -Nr.: HY-145729
CAS. Nr.: 1402357-06-5
Reinheit:  97.96%
Synonyms: AZD9150
Target:  

STAT Apoptosis

Forschungsgebiete:  

Cancer

Danvatirsen (AZD9150) is an antisense oligonucleotide targeting STAT3. Danvatirsen reduces the viability and promotes apoptosis of leukemia cell lines. Danvatirsen inhibits the expression of endogenous STAT3 and its downstream target genes, and reduces the proliferation and tumorigenicity of neuroblastoma and lymphoma cells. Danvatirsen inhibited tumor growth in mouse models of neuroblastoma, lymphoma, and non-small cell lung cancer. Danvatirsen achieves STAT3 mRNA and protein depletion in a mouse model of epidermoid carcinoma. Danvatirsen can be used in research related to lymphoma, myelodysplastic syndrome, acute myeloid leukemia, neuroblastoma and non-small cell lung cancer .
loading...
    loading...
Art. -Nr.: HY-145729A
Reinheit:  97.96%
Synonyms: AZD9150 sodium
Target:  

STAT Apoptosis

Forschungsgebiete:  

Cancer

Danvatirsen sodium (AZD9150 sodium) is an antisense oligonucleotide targeting STAT3. Danvatirsen sodium reduces the viability and promotes apoptosis of leukemia cell lines. Danvatirsen sodium inhibits the expression of endogenous STAT3 and its downstream target genes, and reduces the proliferation and tumorigenicity of neuroblastoma and lymphoma cells. Danvatirsen sodium inhibited tumor growth in mouse models of neuroblastoma, lymphoma, and non-small cell lung cancer. Danvatirsen sodium achieves STAT3 mRNA and protein depletion in a mouse model of epidermoid carcinoma. Danvatirsen sodium can be used in research related to lymphoma, myelodysplastic syndrome, acute myeloid leukemia, neuroblastoma and non-small cell lung cancer .
loading...
    loading...
Art. -Nr.: HY-181166
Target:  

EGFR Apoptosis

Forschungsgebiete:  

Cancer

EGFR-IN-194 is a potent EGFR tyrosine kinase inhibitor with an IC50 of 54.3 nM against human EGFR. EGFR-IN-194 induces apoptosis, inhibits migration in cancer cells, selectively promotes invasion in cancer cells, and exhibits antiproliferative effects across multiple cancer cell lines. EGFR-IN-194 can be used for the research of prostate adenocarcinoma, non-small cell lung carcinoma, breast carcinoma, chronic myeloid leukemia .
loading...
    loading...
Art. -Nr.: HY-N6052A
CAS. Nr.: 607363-34-8
Synonyms: 3-Hydroxy-9-methoxypterocarpan
(Rac)-Medicarpin (3-Hydroxy-9-methoxypterocarpan) is a pterocarpan isoflavonoid phytoalexin with antimicrobial activity and anti-tumor promoting activity. (Rac)-Medicarpin induces apoptosis in human peripheral blood mononuclear cells. (Rac)-Medicarpin is also a defensive secondary metabolite produced in sword bean calli in response to exposure to spore suspensions of the non-pathogenic fungus Pithomyces chartarum or HgCl2 .
loading...
    loading...
Art. -Nr.: HY-118713
CAS. Nr.: 133401-10-2
Kuanoniamine A is a pyridoacridine alkaloid and also an anticancer agent. Kuanoniamine A inhibits DNA synthesis, induces apoptosis, and regulates the cell cycle by reducing the proportion of cells in the G2/M phase. Kuanoniamine A inhibits the proliferation of human lymphocytes. Kuanoniamine A can be used in research related to breast cancer, glioma, non-small cell lung cancer, and melanoma .
loading...
    loading...
Art. -Nr.: HY-19896A
CAS. Nr.: 1204956-74-0
COTI-2 hydrochloride is an orally active thiosemicarbazone anticancer agent and p53 mutant activator. COTI-2 hydrochloride induces Apoptosis. COTI-2 hydrochloride triggers the activation of AMPK and the inhibition of the mTOR pathway. COTI-2 hydrochloride induces DNA damage and replication stress responses. COTI-2 hydrochloride binds to misfolded mutant p53 proteins, thereby inducing conformational changes that restore p53 to its normal state and reactivate its function. COTI-2 hydrochloride acts on a variety of cancer cell lines and xenografts. COTI-2 hydrochloride can be used in research related to colorectal cancer, small cell lung cancer, glioblastoma, breast cancer, and ovarian cancer .
loading...
    loading...